Literature DB >> 21252128

Effect of methotrexate treatment of ectopic pregnancy on subsequent pregnancy.

Rinat Hackmon, Sachi Sakaguchi, Gideon Koren.   

Abstract

QUESTION: My last pregnancy was diagnosed as ectopic, and I was treated successfully with intramuscular methotrexate (MTX) 8 weeks ago. I am currently planning for another pregnancy; however, I have read that MTX causes birth defects and that it stays in my body for a very long time, ranging from 1 to 12 months after treatment. When is it safe to conceive? ANSWER: We suggest that the outcomes of pregnancies conceived shortly after MTX therapy for extrauterine pregnancy are most likely to be favourable and similar to those pregnancies conceived 6 months after MTX treatment. However, as data are not sufficient to draw a definitive conclusion or to confirm the exact safe timing after MTX treatment, at least a 3-month waiting period is recommended for women who are planning pregnancy. Nevertheless, conception within 3 months of MTX treatment of extrauterine pregnancy should not be considered a definite indication of termination, and further targeted fetal anatomy assessment is recommended. Further retrospective and prospective studies are needed to define the safety period before 3 months and to solidify this recommendation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21252128      PMCID: PMC3024157     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  13 in total

Review 1.  The effects of methotrexate on pregnancy, fertility and lactation.

Authors:  M E Lloyd; M Carr; P McElhatton; G M Hall; R A Hughes
Journal:  QJM       Date:  1999-10

2.  Effect of methotrexate on male fertility.

Authors:  Amy E French; Gideon Koren
Journal:  Can Fam Physician       Date:  2003-05       Impact factor: 3.275

Review 3.  Clinical teratology counseling and consultation case report: low dose methotrexate exposure in the early weeks of pregnancy.

Authors:  M Feldkamp; J C Carey
Journal:  Teratology       Date:  1993-06

4.  Methotrexate exposure prior to and during pregnancy.

Authors:  A E Donnenfeld; A Pastuszak; J S Noah; B Schick; N C Rose; G Koren
Journal:  Teratology       Date:  1994-02

5.  Risk of abnormal pregnancy completing chemotherapy for gestational trophoblastic tumor.

Authors:  Hideo Matsui; Yoshinori Iitsuka; Kiyomi Suzuka; Koji Yamazawa; Naotake Tanaka; Katsuyoshi Seki; Souei Sekiya
Journal:  Gynecol Oncol       Date:  2003-02       Impact factor: 5.482

Review 6.  Systematic review on the safety of methotrexate in rheumatoid arthritis regarding the reproductive system (fertility, pregnancy, and breastfeeding).

Authors:  J A Martínez Lopez; E Loza; L Carmona
Journal:  Clin Exp Rheumatol       Date:  2009 Jul-Aug       Impact factor: 4.473

7.  The safety of conception occurring shortly after methotrexate treatment of an ectopic pregnancy.

Authors:  Ran Svirsky; Uri Rozovski; Zvi Vaknin; Moty Pansky; David Schneider; Reuvit Halperin
Journal:  Reprod Toxicol       Date:  2008-12-03       Impact factor: 3.143

8.  Pregnancy after cytotoxic chemotherapy for gestational trophoblastic tumours.

Authors:  G J Rustin; M Booth; J Dent; S Salt; F Rustin; K D Bagshawe
Journal:  Br Med J (Clin Res Ed)       Date:  1984-01-14

9.  Embryotoxicity of the folate antagonist methotrexate in rats and rabbits.

Authors:  R L Jordan; J G Wilson; H J Schumacher
Journal:  Teratology       Date:  1977-02

Review 10.  Disease-modifying antirheumatic drugs, including methotrexate, gold, sulfasalazine, antimalarials, and D-penicillamine.

Authors:  P G Conaghan; P Brooks
Journal:  Curr Opin Rheumatol       Date:  1996-05       Impact factor: 5.006

View more
  5 in total

1.  Pregnancy of unknown location.

Authors:  Pedro Paulo Pereira; Fábio Roberto Cabar; Úrsula Trovato Gomez; Rossana Pulcineli Vieira Francisco
Journal:  Clinics (Sao Paulo)       Date:  2019-10-14       Impact factor: 2.365

2.  The effects of conventional drugs in the treatment of rheumatoid arthritis on the serum lipids.

Authors:  Mansoor Karimifar; Mohammad S Sepehrifar; Hamidreza Moussavi; Mohammad B Sepehrifar; Peyman Mottaghi; Mansour Siavash; Mozhgan Karimifar
Journal:  J Res Med Sci       Date:  2018-12-28       Impact factor: 1.852

3.  Setting priorities in the conventional approaches in managing ectopic pregnancy; is it time to reform? A teaching hospital experience.

Authors:  Kamil M Fram; Shawqi Saleh; Fidaa Thikerallah; Farah Fram; Rand Fram; Hadeel Rawahneh; Mai Khrais; Tamara Darwish
Journal:  Prz Menopauzalny       Date:  2020-01-15

4.  Which Protocol is better for Treatment of Ectopic Pregnancy by Methotrexate? Single-dose or Multiple-dose.

Authors:  Behnaz Khani; Fariba Behnamfar; Leila Taghiyar
Journal:  Adv Biomed Res       Date:  2020-10-30

5.  Effectiveness and safety of ultrasound-guided intramuscular lauromacrogol injection combined with hysteroscopy in cervical pregnancy treatment: A case report.

Authors:  Jian-Pei Ye; Yang Gao; Li-Wei Lu; Yong-Ju Ye
Journal:  World J Clin Cases       Date:  2022-06-26       Impact factor: 1.534

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.